Systematic review of transcriptome and microRNAome associations with gestational diabetes mellitus

KA Lewis, L Chang, J Cheung, BE Aouizerat… - Frontiers in …, 2023 - frontiersin.org
Purpose Gestational diabetes (GDM) is associated with increased risk for preterm birth and
related complications for both the pregnant person and newborn. Changes in gene …

Relationship of miRNA‑126 and miRNA‑122 expression with type 2 diabetes mellitus and related glucose metabolism parameters: A systematic review and meta …

Y He, Y Li, Z Zhai, P Liu, L Nie… - Experimental and …, 2022 - spandidos-publications.com
There are increasing numbers of studies investigating the potential link between microRNAs
(miRNAs) and type 2 diabetes mellitus (T2DM) risk. Based on the prior evidence and the …

Association of rs2910164 in miR-146a with type 2 diabetes mellitus: A case–control and meta-analysis study

WW Chang, LY Wen, L Zhang, X Tong, YL Jin… - Frontiers in …, 2022 - frontiersin.org
Objective Several studies have shown that miR-146a rs2910164 (C> G) is associated with
type 2 diabetes mellitus (T2DM) susceptibility, but the results are still controversial. This …

The role of racial and ethnic factors in microRNA expression and risk for type 2 diabetes

E Flowers, AM Kanaya, L Zhang, BE Aouizerat - Frontiers in Genetics, 2022 - frontiersin.org
Prior studies focused on circulating microRNAs and the risk for complex diseases have
shown inconsistent findings. The majority of studies focused on European and East Asian …

MicroRNAs Associated with Metformin Treatment in the Diabetes Prevention Program

KA Lewis, BM Stroebel, L Zhang, B Aouizerat… - International Journal of …, 2024 - mdpi.com
The Diabetes Prevention Program (DPP) randomized controlled trial demonstrated that
metformin treatment reduced progression to type 2 diabetes (T2D) by 31% compared to …

Identification of de-regulated circulating microRNAs as putative biomarkers in amyotrophic lateral sclerosis

NDP Elias - 2023 - repositorio.ul.pt
Amyotrophic Lateral Sclerosis (ALS) is a heterogeneous and progressive
neurodegenerative disease. Diagnostic delays are a challenge in the management of ALS …